Vanda Pharmaceuticals Inc. (VNDA) › Net IncomeVanda Pharmaceuticals Inc. (VNDA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$35.86M2010: $7.19M2011: -$9.80M2012: -$28.62M2013: -$21.05M2014: $20.19M2015: -$39.87M2016: -$18.01M2017: -$15.57M2018: $25.21M2019: $115.55M2020: $23.34M2021: $33.15M2022: $6.28M2023: $2.51M2024: -$18.90M2025: -$220.47M-$220.47M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$220.47M-1066.5%2024-$18.90M-853.3%2023$2.51M-60.0%2022$6.28M-81.1%2021$33.15M+42.1%2020$23.34M-79.8%2019$115.55M+358.4%2018$25.21M+261.9%2017-$15.57M+13.6%2016-$18.01M+54.8%2015-$39.87M-297.5%2014$20.19M+195.9%2013-$21.05M+26.4%2012-$28.62M-192.0%2011-$9.80M-236.3%2010$7.19M+120.1%2009-$35.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share